Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 1;134(8):886-894.
doi: 10.1097/CM9.0000000000001410.

Clinical practice guidelines for sentinel lymph node biopsy in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021

Jing-Ming Ye  1 , Bao-Liang Guo  2 , Qian Liu  1 , Fei Ma  2 , Hong-Jin Liu  1 , Qian Wu  1 , Ling Xin  1 , Yuan-Jia Cheng  1 , Hong Zhang  3 , Shuang Zhang  3 , Xue-Ning Duan  1 , Jian-Guo Zhang  2 , Yin-Hua Liu  1 ; Chinese Society of Breast Surgery
Affiliations

Clinical practice guidelines for sentinel lymph node biopsy in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021

Jing-Ming Ye et al. Chin Med J (Engl). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The expert committee for these guidelines declares no conflict of interest. These guidelines are a reference for breast disease specialists in clinical practice. However, the guidelines are not to be used as the basis for medical evaluation, and do not play an arbitrating role in the handling of any medical disputes. The guidelines are not a reference for patients or non-breast specialists. The Chinese Society of Breast Surgery assumes no responsibility for results involving the inappropriate application of these guidelines, and reserves the right to interpret and revise the guidelines.

Data sharing: no additional data available.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Latosinsky S, Dabbs K, Moffat F. Canadian Association of General Surgeons and American College of Surgeons Evidence-Based Reviews in Surgery. 27. Quality-of-life outcomes with sentinel node biopsy versus standard axillary treatment in patients with operable breast cancer. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. Can J Surg 2008; 51:483–485. - PMC - PubMed
    1. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. . Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010; 11:927–933. doi: 10.1016/s1470-2045(10)70207-2. - PMC - PubMed
    1. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. . Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006; 98:599–609. doi: 10.1093/jnci/djj158. - PubMed
    1. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. . A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. NEJM 2003; 349:546–553. doi: 10.1056/NEJMoa012782. - PubMed
    1. NCCN Clinical Practice Guidelines in Oncology: Breast cancer. Version 4, 2020. Plymouth Meeting: National Comprehensive Cancer Network, 2020. Available from: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf/. [Accessed 2020 December 18, 2020].